Brain, Vol. 125, No. 5, 1070-1083,
May 2002
© 2002 Guarantors of Brain
Progression and prognosis in multiple system atrophy
An analysis of 230 Japanese patients
1 Department of Neurology and 2 Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, 3 Department of Neurology, Nagoya National Hospital, 4 Department of Neurology, Higashi Nagoya National Hospital, 5 Department of Neurology, Nagoya Daini Red Cross Hospital, Nagoya, 6 Division of Neurology, Department of General Medicine, Aichi Medical University and 7 Department of Neurology, Chubu National Hospital, Japan
Correspondence to: G. Sobue, Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan E-mail: sobueg{at}tsuru.med.nagoya-u.ac.jp
We investigated the disease progression and survival in 230 Japanese patients with multiple system atrophy (MSA; 131 men, 99 women; 208 probable MSA, 22 definite; mean age at onset, 55.4 years). Cerebellar dysfunction (multiple system atrophycerebellar; MSA-C) predominated in 155 patients, and parkinsonism (multiple system atrophyparkinsonian; MSA-P) in 75. The median time from initial symptom to combined motor and autonomic dysfunction was 2 years (range 110). Median intervals from onset to aid-requiring walking, confinement to a wheelchair, a bedridden state and death were 3, 5, 8 and 9 years, respectively. Patients manifesting combined motor and autonomic involvement within 3 years of onset had a significantly increased risk of not only developing advanced disease stage but also shorter survival (P < 0.01). MSA-P patients had more rapid functional deterioration than MSA-C patients (aid-requiring walking, P = 0.03; confinement to a wheelchair, P < 0.01; bedridden state, P < 0.01), but showed similar survival. Onset in older individuals showed increased risk of confinement to a wheelchair (P < 0.05), bedridden state (P = 0.03) and death (P < 0.01). Patients initially complaining of motor symptoms had accelerated risk of aid-requiring walking (P < 0.01) and confinement to a wheelchair (P < 0.01) compared with those initially complaining of autonomic symptoms, while the time until confinement to a bedridden state and survival were no worse. Gender was not associated with differences in worsening of function or survival. On MRI, a hyperintense rim at the lateral edge of the dorsolateral putamen was seen in 34.5% of cases, and a hot cross bun sign in the pontine basis (PB) in 63.3%. These putaminal and pontine abnormalities became more prominent as MSA-P and MSA-C features advanced. The atrophy of the cerebellar vermis and PB showed a significant correlation particularly with the interval following the appearance of cerebellar symptoms in MSA-C (r = 0.71, P < 0.01, r = 0.76 and P < 0.01, respectively), but the relationship between atrophy and functional status was highly variable among the individuals, suggesting that other factors influenced the functional deterioration. Atrophy of the corpus callosum was seen in a subpopulation of MSA, suggesting hemispheric involvement in a subgroup of MSA patients. The present study suggested that many factors are involved in the progression of MSA but, most importantly, the interval from initial symptom to combined motor and autonomic dysfunction can predict functional deterioration and survival in MSA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M Nakajima, H Kojima, Y Takazawa, N Yahagi, K Harada, K Takahashi, K Unuma, and K Yoshida An autopsy report on multiple system atrophy diagnosed immunohistochemically despite severe ischaemic damage: a new approach for investigation of medical practice associated deaths in Japan J. Clin. Pathol., November 1, 2009; 62(11): 1029 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tada, A. Kakita, Y. Toyoshima, O. Onodera, T. Ozawa, T. Morita, M. Nishizawa, and H. Takahashi Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death Brain, July 1, 2009; 132(7): 1810 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, W. Shirai, and T. Hattori Putaminal Hyperintensity on T1-Weighted MR Imaging in Patients with the Parkinson Variant of Multiple System Atrophy AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 689 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bensimon, A. Ludolph, Y. Agid, M. Vidailhet, C. Payan, P. N. Leigh, and for the NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study Brain, January 1, 2009; 132(1): 156 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, and A. J. Lees Clinical outcomes of progressive supranuclear palsy and multiple system atrophy Brain, May 1, 2008; 131(5): 1362 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawai, M. Suenaga, A. Takeda, M. Ito, H. Watanabe, F. Tanaka, K. Kato, H. Fukatsu, S. Naganawa, T. Kato, et al. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P Neurology, April 15, 2008; 70(16_Part_2): 1390 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dormont, D.J. Seidenwurm, and for the Expert Panel on Neurologic Imaging Dementia and Movement Disorders AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 204 - 206. [Full Text] [PDF] |
||||
![]() |
M. Ito, H. Watanabe, Y. Kawai, N. Atsuta, F. Tanaka, S. Naganawa, H. Fukatsu, and G. Sobue Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 722 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shibao, S. R. Raj, A. Gamboa, A. Diedrich, L. Choi, B. K. Black, D. Robertson, and I. Biaggioni Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function Hypertension, July 1, 2007; 50(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimohata, H. Shinoda, H. Nakayama, T. Ozawa, K. Terajima, H. Yoshizawa, Y. Matsuzawa, O. Onodera, S. Naruse, K. Tanaka, et al. Daytime Hypoxemia, Sleep-Disordered Breathing, and Laryngopharyngeal Findings in Multiple System Atrophy Arch Neurol, June 1, 2007; 64(6): 856 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hara, Y. Momose, S. Tokiguchi, M. Shimohata, K. Terajima, O. Onodera, A. Kakita, M. Yamada, H. Takahashi, M. Hirasawa, et al. Multiplex Families With Multiple System Atrophy Arch Neurol, April 1, 2007; 64(4): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papapetropoulos, A. Tuchman, D. Laufer, A. G Papatsoris, N. Papapetropoulos, and D. C Mash Causes of death in multiple system atrophy J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 327 - 329. [Full Text] [PDF] |
||||
![]() |
M. Tada, O. Onodera, M. Tada, T. Ozawa, Y.-S. Piao, A. Kakita, H. Takahashi, and M. Nishizawa Early Development of Autonomic Dysfunction May Predict Poor Prognosis in Patients With Multiple System Atrophy Arch Neurol, February 1, 2007; 64(2): 256 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Abdo, B.P.C. van de Warrenburg, M. Munneke, W. J.A. van Geel, B. R. Bloem, H. P.H. Kremer, and M. M. Verbeek CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia Neurology, August 8, 2006; 67(3): 474 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S M Taylor and C. Counsell Is it Parkinson's disease, and if not, what is it? Practical Neurology, June 1, 2006; 6(3): 154 - 165. [Full Text] [PDF] |
||||
![]() |
D. C. Paviour, S. L. Price, M. Jahanshahi, A. J. Lees, and N. C. Fox Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy Brain, April 1, 2006; 129(4): 1040 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Lee, C.-C. Lee, W.-C. Shyu, P.-N. Chong, and S.-Z. Lin Hyperintense Putaminal Rim Sign Is Not a Hallmark of Multiple System Atrophy at 3T AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2238 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kamm, D. G. Healy, N. P. Quinn, U. Wullner, J. C. Moller, L. Schols, F. Geser, K. Burk, A. D. Borglum, M. T. Pellecchia, et al. The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group Brain, August 1, 2005; 128(8): 1855 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Mabuchi, M Hirayama, Y Koike, H Watanabe, H Ito, R Kobayashi, K Hamada, and G Sobue Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 947 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shibao, A. Gamboa, A. Diedrich, and I. Biaggioni Management of Hypertension in the Setting of Autonomic Failure: A Pathophysiological Approach Hypertension, April 1, 2005; 45(4): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hemingway, K. Franco, and E. Chmelik Shy-Drager Syndrome: Multisystem Atrophy With Comorbid Depression Psychosomatics, February 1, 2005; 46(1): 73 - 76. [Full Text] [PDF] |
||||
![]() |
T. Ozawa, D. Paviour, N. P. Quinn, K. A. Josephs, H. Sangha, L. Kilford, D. G. Healy, N. W. Wood, A. J. Lees, J. L. Holton, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations Brain, December 1, 2004; 127(12): 2657 - 2671. [Abstract] [Full Text] [PDF] |
||||
![]() |
M B Muzaimi, J Thomas, S Palmer-Smith, L Rosser, P S Harper, C M Wiles, D Ravine, and N P Robertson Population based study of late onset cerebellar ataxia in south east Wales J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanabe, H. Fukatsu, N. Hishikawa, Y. Hashizume, and G. Sobue Field strengths and sequences influence putaminal MRI findings in multiple system atrophy Neurology, February 24, 2004; 62(4): 671 - 671. [Full Text] [PDF] |
||||
![]() |
A. A. Migliaccio, G. M. Halmagyi, L. A. McGarvie, and P. D. Cremer Cerebellar ataxia with bilateral vestibulopathy: description of a syndrome and its characteristic clinical sign Brain, February 1, 2004; 127(2): 280 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Watanabe, H Fukatsu, M Katsuno, M Sugiura, K Hamada, Y Okada, M Hirayama, T Ishigaki, and G Sobue Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Lu, Y.-H. Weng, M.-C. Chen, R.-S. Chen, K.-Y. Tzen, S.-P. Wey, G. Ting, H.-C. Chang, and T.-C. Yen 99mTc-TRODAT-1 Imaging of Multiple System Atrophy J. Nucl. Med., January 1, 2004; 45(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Higo, N Tayama, T Watanabe, T Nitou, and S Takeuchi Vocal fold motion impairment in patients with multiple system atrophy: evaluation of its relationship with swallowing function J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 982 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Seppi, M.F.H. Schocke, R. Esterhammer, C. Kremser, C. Brenneis, J. Mueller, S. Boesch, W. Jaschke, W. Poewe, and G.K. Wenning Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy Neurology, March 25, 2003; 60(6): 922 - 927. [Abstract] [Full Text] [PDF] |
||||









